Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China.
Department of Obstetrics and Gynecology, Second Hospital of Shanxi Medical University, Shanxi, China.
Front Endocrinol (Lausanne). 2022 Jul 29;13:865358. doi: 10.3389/fendo.2022.865358. eCollection 2022.
Adenomyosis is commonly encountered in infertile women; however, it is still unclear whether adenomyosis has a detrimental effect on fertilization and embryo transfer (IVF-ET) outcomes.
We enrolled 1146 patients with adenomyosis and 1146 frequency-matched control women in a 1:1 ratio based on age, BMI, and basal follicle-stimulating hormone (FSH) level. After controlling for other factors, the rates of clinical pregnancy, miscarriage, live birth, and obstetric complications were compared between two groups.
There was no significant difference in clinical pregnancy rate between the two groups (38.1% vs. 41.6%; P=0.088). The implantation rate (25.6% versus 28.6%, P=0.027) and live birth rate (26% versus 31.5%, P=0.004) were significantly lower in the women with adenomyosis than in the controls. The miscarriage rate in the adenomyosis group was higher than that in the control group (29.1% versus 17.2%, P=0.001). After adjusting for confounding factors, multivariate analysis showed the clinical pregnancy rate was not statistically different between the two groups (OR: 0.852, P=0.070). In the adenomyosis group, the rate of miscarriage(OR: 1.877, P=0.000), placenta previa (OR: 2.996, P=0.042)and preeclampsia (OR: 2.287, P=0.042)were increased significantly, while live birth rate (OR: 0.541, P=0.000) was reduced significantly than control group.
Adenomyosis has negative effect on IVF-ET outcomes in which miscarriage risk increased, live birth rate reduced and obstetric complications increased.
子宫腺肌病在不孕妇女中很常见,但目前尚不清楚子宫腺肌病是否对受精和胚胎移植(IVF-ET)结局有不良影响。
我们按照年龄、BMI 和基础卵泡刺激素(FSH)水平,以 1:1 的比例纳入 1146 例子宫腺肌病患者和 1146 例频率匹配的对照组妇女。在控制其他因素后,比较两组的临床妊娠率、流产率、活产率和产科并发症发生率。
两组的临床妊娠率无显著差异(38.1%比 41.6%;P=0.088)。子宫腺肌病组的种植率(25.6%比 28.6%,P=0.027)和活产率(26%比 31.5%,P=0.004)显著低于对照组。子宫腺肌病组的流产率高于对照组(29.1%比 17.2%,P=0.001)。调整混杂因素后,多变量分析显示两组的临床妊娠率无统计学差异(OR:0.852,P=0.070)。在子宫腺肌病组,流产率(OR:1.877,P=0.000)、前置胎盘(OR:2.996,P=0.042)和子痫前期(OR:2.287,P=0.042)的发生率显著增加,而活产率(OR:0.541,P=0.000)显著降低。
子宫腺肌病对 IVF-ET 结局有不良影响,表现为流产风险增加、活产率降低和产科并发症增加。